Hepatitis B vaccination in preterm infants
Department of
Paediatrics, Mackay Memorial Hospital, Department of Pediatrics,
National Taiwan University Hospital, Taipei, Taiwan
Correspondence to: Dr Chin-Yun Lee, Department of Paediatrics, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan.
Accepted 18 April 1997
AIM
To investigate the immunogenicity and safety
of existing recommendations for hepatitis B vaccination in preterm infants.
METHODS
Recombinant hepatitis B vaccine (H-B-VAX
II, 5 µg per dose) was given to 85 preterm infants divided into two
groups, using two different schedules. Forty four group A infants with
birthweights of < 2000 g received three doses at 1, 2, and 7 months of
age. Forty one group B infants with birthweights of
2000 g received three doses at 0, 1, and 6 months of age.
RESULTS
After vaccination, 42 infants from group A
(95%) and 37 infants from group B (90%) developed protective levels
of antibody. The final seropositive rate and the geometric mean
concentration of hepatitis B surface antibody between the two groups
were not significantly different. The immune response of preterm
infants to hepatitis B vaccines was similar to that of term infants in a previous study.
CONCLUSIONS
Preterm infants can be given hepatitis
B vaccines using one of the above two different schedules, at a cutoff
birthweight of 2000 g.
© 1997 by Archives of Disease in Childhood
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



